Anke Sparmann
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- CRISPR and Genetic Engineering 3
- RNA modifications and cancer 2
- RNA regulation and disease 2
- RNA Research and Splicing 2
- RNA and protein synthesis mechanisms 2
- Epigenetics and DNA Methylation 2
- Co-authors
- Maarten van Lohuizen (2 shared papers)Dafna Bar‐Sagi (2 shared papers)Jörg Vogel (2 shared papers)Michiel Vermeulen (1 shared paper)Cesare Lancini (1 shared paper)Juergen A. Knoblich (1 shared paper)Els Verhoeven (1 shared paper)Yunli Xie (1 shared paper)
- Journals
- Nature Structural & Molecular Biology (3 papers)The EMBO Journal (2 papers)Cancer Cell (1 paper)Molecular Systems Biology (1 paper)Cell Cycle (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Anke Sparmann
10 papers receiving 1.9k citations
Anke Sparmann's Hit Papers
Peers
Comparison fields: 5 of 91
- Cancer Research 401
- Oncology 532
- Molecular Biology 1.3k
- Immunology 370
- Immunology and Allergy 48
Countries citing papers authored by Anke Sparmann
This map shows the geographic impact of Anke Sparmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Sparmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Sparmann more than expected).
Fields of papers citing papers by Anke Sparmann
This network shows the impact of papers produced by Anke Sparmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Sparmann. The network helps show where Anke Sparmann may publish in the future.
Co-authors
The 15 scholars most cited alongside Anke Sparmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Polycomb silencers control cell fate, development and cancer Hit paper breakdown → | 2006 | 1075 |
| 2 | 2004 | 719 | |
| 3 | 2023 | 86 | |
| 4 | 2013 | 71 | |
| 5 | 2005 | 17 | |
| 6 | 2025 | 4 | |
| 7 | 2021 | 2 | |
| 8 | 2019 | 1 | |
| 9 | 2017 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2015 | 0 |
About Anke Sparmann
Anke Sparmann is a scholar working on Molecular Biology, Immunology, Oncology, Genetics and Psychiatry and Mental health, having authored 11 papers that have together received 2.0k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (3 papers), RNA modifications and cancer (2 papers), RNA regulation and disease (2 papers), Chemokine receptors and signaling (2 papers), RNA Research and Splicing (2 papers), RNA and protein synthesis mechanisms (2 papers), Epigenetics and DNA Methylation (2 papers) and Genetics and Neurodevelopmental Disorders (2 papers). The work is most often cited by research in Cancer Research (401 citations), Oncology (532 citations), Molecular Biology (1.3k citations), Immunology (370 citations) and Immunology and Allergy (48 citations). Anke Sparmann has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Maarten van Lohuizen, Dafna Bar‐Sagi, Jörg Vogel, Michiel Vermeulen, Cesare Lancini, Juergen A. Knoblich, Els Verhoeven, Yunli Xie, Gaetano Gargiulo and Matthias Mann. Their work appears in journals such as Nature Structural & Molecular Biology, The EMBO Journal, Cancer Cell, Molecular Systems Biology and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.